Re: [新聞] 智擎最新胰臟癌新藥進度
作者: jackred (我在台北天氣晴) 2015-01-18 16:56:46
大家所關心的藥證申請進度
網址:
![]()
In November 2014, the FDA granted MM-398 plus 5-FU and leucovorin a Fast
Track designation as a second-line treatment for patients with metastatic
pancreatic cancer, based on data from the NAPOLI-1 study. As part of this
review program, the company developing MM-298, Merrimack Pharmaceuticals, can
submit information for a New Drug Application for MM-398 to the FDA in
sections. The company plans to complete this submission process within the
first few months of 2015.
網址:
In November 2014, the FDA granted MM-398 plus 5-FU and leucovorin a Fast
Track designation as a second-line treatment for patients with metastatic
pancreatic cancer, based on data from the NAPOLI-1 study. As part of this
review program, the company developing MM-298, Merrimack Pharmaceuticals, can
submit information for a New Drug Application for MM-398 to the FDA in
sections. The company plans to complete this submission process within the
first few months of 2015.